EIF4EBP1 and gastric adenocarcinoma: In contrast, the expression of 4EBP1 exhibits a decreasing tendency as the pathological stage promoting in two digestive system tumors, namely colon adenocarcinoma (COAD) and stomach adenocarcinoma (STAD) (Figures 1C,J).